BridgeBio Pharma, Inc.
BBIO
$68.55
$2.603.94%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 940.19M | 587.48M | 645.94M | 756.89M | 540.60M |
| Total Receivables | 205.23M | 139.44M | 116.52M | 76.87M | 115.27M |
| Inventory | 32.98M | 26.75M | 24.53M | 18.28M | 3.95M |
| Prepaid Expenses | 62.91M | 38.42M | 47.37M | 54.89M | 32.13M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 5.95M | 5.65M | 5.03M | 5.35M | 3.23M |
| Total Current Assets | 1.24B | 797.75M | 839.38M | 912.28M | 695.17M |
|
|
|||||
| Total Current Assets | 1.24B | 797.75M | 839.38M | 912.28M | 695.17M |
| Net Property, Plant & Equipment | 22.17M | 13.52M | 12.38M | 12.29M | 13.86M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 27.36M | 28.08M | 28.80M | 29.51M | 27.80M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 18.62M | 16.71M | 25.52M | 18.11M | 16.61M |
| Total Assets | 1.37B | 936.03M | 998.25M | 1.08B | 881.64M |
|
|
|||||
| Total Accounts Payable | 29.06M | 36.23M | 18.70M | 26.13M | 27.53M |
| Total Accrued Expenses | 93.77M | 238.36M | 183.52M | 129.90M | 103.25M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 551.92M | 6.19M | 5.29M | 4.78M | 5.21M |
| Total Finance Division Other Current Liabilities | 141.62M | 7.19M | 9.09M | 15.04M | 16.12M |
| Total Other Current Liabilities | 141.62M | 7.19M | 9.09M | 15.04M | 16.12M |
| Total Current Liabilities | 816.37M | 287.97M | 216.60M | 175.85M | 152.11M |
|
|
|||||
| Total Current Liabilities | 816.37M | 287.97M | 216.60M | 175.85M | 152.11M |
| Long-Term Debt | 1.93B | 1.85B | 1.85B | 1.85B | 1.85B |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 14.22M | 3.81M | 3.43M | 4.03M | 4.92M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 883.19M | 868.35M | 849.94M | 829.17M | 515.16M |
| Total Liabilities | 3.64B | 3.01B | 2.92B | 2.86B | 2.52B |
|
|
|||||
| Common Stock & APIC | 2.11B | 2.06B | 2.02B | 1.98B | 1.94B |
| Retained Earnings | -3.99B | -3.82B | -3.63B | -3.45B | -3.26B |
| Treasury Stock & Other | -405.78M | -323.26M | -323.27M | -323.28M | -323.28M |
| Total Common Equity | -2.28B | -2.09B | -1.93B | -1.79B | -1.65B |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -2.28B | -2.09B | -1.93B | -1.79B | -1.65B |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | 9.49M | 10.03M | 10.34M | 9.44M | 9.73M |
| Total Equity | -2.27B | -2.08B | -1.92B | -1.78B | -1.64B |
|
|
|||||